Regarding the biological mechanism, R-2HG was shown to inhibit FTO activity, thus increasing the m6A mRNA modification in R-2HG-sensitive leukemia cells, reducing the stability of MYC/CEBPA transcripts, and inhibiting the related pathways. This evidence concerns the gene MYC and leukemia.